title: Phase II study of 5-fluorouracil (5-FU) and high dose folinic acid (HDFA) in hepatocellular carcinoma.
authors.affiliation: IIIa Divisione di Medicina Generale, Fondazione Beretta Spedali Civili, Brescia, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Zaniboni
authors.forename: E
authors.initials: E
authors.lastname: Simoncini
authors.forename: P
authors.initials: P
authors.lastname: Marpicati
authors.forename: G
authors.initials: G
authors.lastname: Marini
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage; D008113:Liver Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
chemical_list: D002955:Leucovorin; D005472:Fluorouracil